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Background: Although there has been a resurgence of try-
panosomiasis in many countries in sub-Saharan Africa since
the early 1970s, the risk to short-term travellers and expatri-
ates remains small. However, East African trypanosomiasis
(EAT) is an acute life-threatening disease, and diagnosis and
treatment are challenging.
Methods: NICD is a centre for surveillance of com-
municable diseases and operates an advisory service for
clinicians and public health practitioners. Serious and
unusual imported cases therefore come to our attention. We
describe the epidemiological features, clinical presentation
and outcomes of 18 travellers with EAT managed in South
Africa between 2001 and 2008.
Results: Most patients acquired the infection in Malawi,
notably in the Kasungu National Park, with the remainder
presenting after visiting game parks in Kenya, Zimbabwe,
Uganda and Tanzania. Thirteen patients were tourists, one
was a Zambezi valley farmer and 4 were involved in con-
servation or army ﬁeld exercises. Incubation periods were
generally less than 10 days, and disease was typically acute
with fever and headache, and trypanosomal chancres in at
least 50%. Malaria was the most frequent misdiagnosis and
several patients received malaria treatment despite per-
sistently negative laboratory tests. Thrombocytopenia and
varying degrees of renal dysfunction were typical labora-
tory ﬁndings. Three patients had central nervous system
involvement (presence of trypanosomes, and/or leucocyto-
sis and/or raised protein on examination of cerebrospinal
ﬂuid) and required melarsoprol treatment. Suramin treat-
ment was generally well-tolerated with renal dysfunction in
only one patient. Three patients died; one with myocarditis
and arrhythmia, one with multi-organ failure, and one with
a likely melarsoprol-induced encephalopathy. Two patients
were reported to have relapsed after treatment.
Conclusions: East African trypanosomiasis should always
be considered in the differential diagnosis of a febrile
syndrome in travellers from countries where the disease
is endemic. Disease is frequently complicated and expert
laboratory support and clinical management is generally
required.
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Background: In 2005—06 a Chikungunya virus outbreak
nfected 38% of Runion Island population. Forty-two cases
f mother to child transmission were described for the ﬁrst
ime. The purpose of the CHIMERE cohort study was to
etermine the consequences of Chikungunya infection on
regnancy outcomes.
Methods: In 2006, 1401 pregnant women were enrolled
n the CHIMERE cohort. The diagnosis of Chikungunya was
ased either on serology (IgM & IgG Chikungunya speciﬁc
erology) planned at inclusion and at delivery, or RT-PCR
erformed in case of symptoms. We determined that 584
omen were not infected by the virus at delivery (IgM− and
gG−), 648 were infected antepartum (IgM+, RT-PCR+, or
gG seroconversion) and 27 before pregnancy, date of infec-
ion was imprecise for 50 and assessment was incomplete
or 92. We compared pregnancy outcome (prenatal hospital-
zation, fetal-loss and stillbirth, premature delivery, mode
f delivery, birth weight, fetal malformations, newborn
ospitalization) between the 584 women free of Chikun-
unya infection and the 648 infected during pregnancy. This
rospective multicentric study has been approved by IRB
CPP de Tours, France).
Results: For the 648 women infected by Chikungunya
uring pregnancy, the infection occurred during the ﬁrst,
econd, and third trimester for 15, 59 and 26%, respectively;
0% presented fever, 94% arthralgia and 75% skin rash. The
nly difference between non-infected and infected women
as the number of hospitalization during pregnancy (28
ersus 42%, p = 0.0001). Other outcomes, fetal loss and still-
irth (2.2 versus 2.0%), premature delivery (12 versus 10%),
esarean rates (18 versus 16%), birth weight (3067 versus
121 g), fetal malformations (5.0 versus 5.7%) and newborn
ospitalization (6.7 versus 7.4%) were similar.
Conclusion: We do not ﬁnd any impact of Chikungunya
nfection on pregnancy outcomes except for the number of
renatal hospitalizations.
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